Andrea Zanichelli

6.7k total citations · 1 hit paper
111 papers, 3.1k citations indexed

About

Andrea Zanichelli is a scholar working on Genetics, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Andrea Zanichelli has authored 111 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 106 papers in Genetics, 43 papers in Pathology and Forensic Medicine and 31 papers in Rheumatology. Recurrent topics in Andrea Zanichelli's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (106 papers), Autoimmune Bullous Skin Diseases (42 papers) and Urticaria and Related Conditions (30 papers). Andrea Zanichelli is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (106 papers), Autoimmune Bullous Skin Diseases (42 papers) and Urticaria and Related Conditions (30 papers). Andrea Zanichelli collaborates with scholars based in Italy, Germany and United Kingdom. Andrea Zanichelli's co-authors include Marco Cicardi, Lorenza C. Zingale, Massimo Cugno, Hilary Longhurst, Teresa Caballero, Werner Aberer, Marcus Maurer, Chiara Suffritti, Romualdo Vacchini and Sonia Caccia and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Allergy and Clinical Immunology.

In The Last Decade

Andrea Zanichelli

102 papers receiving 3.0k citations

Hit Papers

Classification, diagnosis, and approach to treatment for ... 2014 2026 2018 2022 2014 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group
    2014 413 citations Marco Cicardi, Werner Aberer et al. Allergy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Zanichelli Italy 30 2.8k 1.3k 1.1k 816 735 111 3.1k
Robyn J. Levy United States 19 1.4k 0.5× 580 0.4× 453 0.4× 466 0.6× 521 0.7× 37 1.6k
Jan Samuelsson Sweden 26 1.9k 0.7× 682 0.5× 108 0.1× 174 0.2× 1.9k 2.6× 75 2.8k
Yana Pikman United States 15 2.0k 0.7× 711 0.5× 104 0.1× 116 0.1× 1.8k 2.5× 41 2.7k
Johan Bratt Sweden 21 290 0.1× 952 0.7× 197 0.2× 393 0.5× 370 0.5× 38 1.4k
M Giralt Spain 19 604 0.2× 186 0.1× 202 0.2× 198 0.2× 638 0.9× 50 1.7k
Alvina D. Chu United States 18 422 0.2× 842 0.6× 437 0.4× 728 0.9× 272 0.4× 34 2.2k
Agnès Guerci France 19 1.3k 0.5× 666 0.5× 154 0.1× 83 0.1× 1.9k 2.6× 49 2.1k
I. Tatarsky Israel 21 548 0.2× 146 0.1× 87 0.1× 171 0.2× 873 1.2× 94 1.6k
Shinsaku Hirosawa Japan 18 218 0.1× 47 0.0× 318 0.3× 394 0.5× 355 0.5× 43 1.2k
Hajnalka Andrikovics Hungary 21 358 0.1× 141 0.1× 78 0.1× 151 0.2× 467 0.6× 90 1.2k

Countries citing papers authored by Andrea Zanichelli

Since Specialization
Citations

This map shows the geographic impact of Andrea Zanichelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Zanichelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Zanichelli more than expected).

Fields of papers citing papers by Andrea Zanichelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Zanichelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Zanichelli. The network helps show where Andrea Zanichelli may publish in the future.

Co-authorship network of co-authors of Andrea Zanichelli

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Zanichelli. A scholar is included among the top collaborators of Andrea Zanichelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Zanichelli. Andrea Zanichelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baroni, Irène, Edward Callus, Arianna Magon, et al.. (2025). A COSMIN systematic review of instruments for evaluating health-related quality of life in people with Hereditary Angioedema. Health and Quality of Life Outcomes. 23(1). 12–12.
2.
Zanichelli, Andrea, Walter A. Wuillemin, Emel Aygören‐Pürsün, et al.. (2025). Lanadelumab’s impact on hereditary angioedema control and quality of life across disease activity subgroups. Annals of Allergy Asthma & Immunology. 135(5). 560–569.e2.
3.
Riedl, Marc A., et al.. (2025). Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future. World Allergy Organization Journal. 18(6). 101060–101060.
4.
Berra, Silvia, Chiara Suffritti, Andrea Zanichelli, et al.. (2024). Patterns of C1-Inhibitor Plasma Levels and Kinin–Kallikrein System Activation in Relation to COVID-19 Severity. Life. 14(12). 1525–1525. 1 indexed citations
5.
Cohn, Danny M., Emel Aygören‐Pürsün, Jonathan A. Bernstein, et al.. (2023). Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstat. Clinical and Translational Allergy. 13(9). e12288–e12288. 8 indexed citations
6.
Maurer, Marcus, Markus Magerl, Emel Aygören‐Pürsün, et al.. (2022). Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series. Allergy Asthma and Clinical Immunology. 18(1). 4–4. 6 indexed citations
7.
Banerji, Aleena, Jonathan A. Bernstein, Douglas Johnston, et al.. (2021). Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study. Allergy. 77(3). 979–990. 51 indexed citations
8.
Maurer, Marcus, Teresa Caballero, Werner Aberer, et al.. (2021). Variability of disease activity in patients with hereditary angioedema type 1/2: longitudinal data from the Icatibant Outcome Survey. Journal of the European Academy of Dermatology and Venereology. 35(12). 2421–2430. 3 indexed citations
9.
Loules, Gedeon, Μαρία Ζαμανάκου, Dorottya Csuka, et al.. (2020). Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor. Journal of Clinical Medicine. 9(11). 3402–3402. 21 indexed citations
10.
Meini, Simone, Andrea Zanichelli, Rodolfo Sbrojavacca, et al.. (2020). Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?. Frontiers in Immunology. 11. 2014–2014. 49 indexed citations
11.
Perego, Francesca, Antonio Gidaro, Andrea Zanichelli, et al.. (2020). Life expectancy in Italian patients with hereditary angioedema due to C1-inhibitor deficiency. The Journal of Allergy and Clinical Immunology In Practice. 8(5). 1772–1774. 5 indexed citations
12.
Federici, Carlo, Francesca Perego, Andrea Zanichelli, et al.. (2018). Costs and effects of on-demand treatment of hereditary angioedema in Italy: a prospective cohort study of 167 patients. BMJ Open. 8(7). e022291–e022291. 8 indexed citations
13.
Loffredo, Stefania, Anne Lise Ferrara, Maria Bova, et al.. (2018). Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency. Frontiers in Immunology. 9. 1721–1721. 22 indexed citations
14.
Grumach, Anete Sevciovic, Hilary Longhurst, Werner Aberer, et al.. (2018). Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings. The Journal of Allergy and Clinical Immunology In Practice. 7(3). 1078–1080. 6 indexed citations
15.
16.
Castelli, Roberto, Maddalena Alessandra Wu, Andrea Zanichelli, et al.. (2016). High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency. British Journal of Haematology. 172(6). 902–908. 32 indexed citations
17.
Longhurst, Hilary, Werner Aberer, Laurence Bouillet, et al.. (2015). Analysis of characteristics associated with reinjection of icatibant: Results from the Icatibant Outcome Survey. Allergy and Asthma Proceedings. 36(5). 399–406. 15 indexed citations
18.
Wu, Maddalena Alessandra, et al.. (2015). Current treatment options for hereditary angioedema due to C1 inhibitor deficiency. Expert Opinion on Pharmacotherapy. 17(1). 27–40. 22 indexed citations
19.
Castelli, Roberto, Andrea Zanichelli, Marco Cicardi, & Massimo Cugno. (2013). Acquired C1-inhibitor deficiency and lymphoproliferative disorders: A tight relationship. Critical Reviews in Oncology/Hematology. 87(3). 323–332. 38 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robyn J. Levy Breakdown of academic impact, for papers by Jan Samuelsson Breakdown of academic impact, for papers by Yana Pikman Breakdown of academic impact, for papers by Johan Bratt Breakdown of academic impact, for papers by M Giralt Breakdown of academic impact, for papers by Alvina D. Chu Breakdown of academic impact, for papers by Agnès Guerci Breakdown of academic impact, for papers by I. Tatarsky Breakdown of academic impact, for papers by Shinsaku Hirosawa Breakdown of academic impact, for papers by Hajnalka Andrikovics
Rankless by CCL
2026